GNI Group (2160) · RiskFirst stated
Risk of Intensifying Competition and Obsolescence of Existing Products
First written in FY2019. . Latest entry: FY2019.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Competition Risk from Candidate Product Introduction and Competing Products in the Pharmaceutical MarketA theme 20 companies write about · 22 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2025: 4 of 8 companies on the "Worse" side.
0 other companies' latest entry also says "First stated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 20 companies compared. The sentences above are computed from all 20.